A ceiling “maximum fair price” established by the Inflation Reduction Act will end up being an important driver of ...

The 340B drug pricing plan is meant to help low-income patients. It needs better oversight in this state.

Community health centers that primarily serve low-income patients fear Gov. Bob Ferguson's proposed supplemental budget will hamper their ability to pa ...

The cost of prescription drugs is certain to be a hot-button issue in the coming Illinois legislative session with two separate measures making for curious bedfellows in Springfield.

Sagebrush Health Services has filed a lawsuit against Amgen, alleging unlawful termination of discounted drug sales under the ...

On January 15, 2026, President Trump released a one-page health policy framework. Among other things, the document includes calls for ...

Health Affairs' Rob Lott interviews Sayeh Nikpay of the University of Minnesota about her recent paper exploring how The Medicaid Drug Rebate Program and the 340B Program interact in ways that can ...

The American Hospital Association is asking the Trump administration to stop Eli Lilly from enacting a new policy as part of ...

The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...

Continued support of 340B is vital for diverse communities and small business owners in the state.

Eli Lilly expand 340B reporting requirements to include all covered entities submitting claims-level data by Feb. 1, 2026, with some state exemptions.

Sagebrush Health Services has filed a lawsuit in California state court accusing Amgen of unlawfully cutting off 340B discounted drug sales to its Nevada clinics and reclaiming at least US$7,000,000 ...